Type 2 diabetes
Conditions
Interventions
Intervention group:sleep therapy and auricular-plaster therapy
Sponsors
Community Health Service Center, Yuyuan Street, Huangpu District, Shanghai
Eligibility
Sex/Gender
All
Age
20 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Select aged between 20 and 79 who had already been diagnosed with type 2 diabetes more than 3 months, and the male and female ratio was equal; 2. Patients voluntarily accepted relevant tests during the research, including blood glucose monitoring and sleep monitoring, etc; 3. No drastic changes in living habits, including basic patterns of diet, sleep, and exercise, in the last 2 weeks; 4. No changes in sleep habits such as cross-time zone behavior or night shifts in the last 2 weeks.
Exclusion criteria
Exclusion criteria: 1. Secondary diabetes mellitus, gestational diabetes mellitus, and special types of diabetes; 2. Current acute complications of diabetes, such as diabetic ketosis, hyperglycemic hyperosmolar state, lactic acidosis, etc; 3. Serious cardiovascular and cerebrovascular events within 6 months prior to enrollment, including acute myocardial infarction, unstable angina, poorly controlled arrhythmias, severe heart failure and new cerebrovascular accidents or serious sequelae left from previous cerebrovascular disease; 4. Severe hypertension (systolic blood pressure > 160 mmHg or (and) diastolic blood pressure >100 mmHg) that is poorly controlled by medication; 5. Patients with systemic lupus erythematosus, dermatomyositis, rheumatoid arthritis and other autoimmune diseases; 6. Long-term use of glucocorticoid medication or the current presence of pregnancy, lactation, trauma, acute infection, and other factors affecting fasting glucose or insulin sensitivity; 7. Those with chronic kidney or liver disease, including those with ALT and AST elevated more than 3 times the upper limit of the reference value or more, and eGFR <60ml/min/1.73m2; 8. Those who take sedative-hypnotic drugs irregularly; 9. Combination of other diseases that may affect blood glucose or application of drugs that may affect blood glucose, such as pituitary disease, thyroid disease, adrenal disease, polycystic ovary syndrome, anemia (hemoglobin <120g/l for men and <110g/l for women), blood loss or (and) blood transfusion, application of high-dose vitamin C or erythropoietin, etc; 10. Those with comorbid psychiatric disorders or those whose test protocol may increase their psychological discomfort, and significant cognitive-behavioral impairment; 11. Severe obstructive sleep apnea syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean amplitude of glycemic excursions;time in range;sleep retention rate;the length of light sleep;the length of deep sleep; | — |
Secondary
| Measure | Time frame |
|---|---|
| standard deviation;arousal index; | — |
Countries
China
Contacts
Public ContactSong Jingwen
Community Health Service Center, Yuyuan Street, Huangpu District, Shanghai
Outcome results
None listed